Human Platelets Contain, Translate, and Secrete Azurocidin; A Novel Effect on Hemostasis

Int J Mol Sci. 2022 May 18;23(10):5667. doi: 10.3390/ijms23105667.

Abstract

Platelets play a significant role in hemostasis and perform essential immune functions, evidenced by the extensive repertoire of antimicrobial molecules. Currently, there is no clear description of the presence of azurocidin in human platelets. Azurocidin is a 37 kDa cationic protein abundant in neutrophils, with microbicidal, opsonizing, and vascular permeability-inducing activity. Therefore, this work aimed to characterize the content, secretion, translation, and functions of azurocidin in platelets. Our results show the presence of azurocidin mRNA and protein in α-granules of platelet and megakaryoblasts, and stimulation with thrombin, ADP, and LPS leads to the secretion of free azurocidin as well as within extracellular vesicles. In addition, platelets can translate azurocidin in a basal or thrombin-induced manner. Finally, we found that the addition of low concentrations of azurocidin prevents platelet aggregation and activation. In conclusion, we demonstrate that platelets contain, secrete, and translate azurocidin, and this protein may have important implications for hemostasis.

Keywords: azurocidin; extracellular vesicles; megakaryoblasts; platelet aggregation; platelets; translation.

MeSH terms

  • Antimicrobial Cationic Peptides / metabolism
  • Blood Platelets* / metabolism
  • Blood Proteins* / metabolism
  • Hemostasis
  • Humans
  • Thrombin / metabolism

Substances

  • AZU1 protein, human
  • Antimicrobial Cationic Peptides
  • Blood Proteins
  • Thrombin

Grants and funding

This research received no external funding.